Table 4.
Summary of in vitro induction studies with pregnancy hormones for CYPs and UGTs involved in THC, 11-OH-THC, and 11-COOH-THC clearance.
Target Enzyme | Hormone | Change | References |
---|---|---|---|
| |||
CYP2C9 | Estradiol | Increase in activity but no change in expression | [147] |
CYP2C9 | Cortisol | Evidence of GR response element | [148] |
CYP3A4 | Growth hormones | No change in activity or expression and an increase in expression | [149,150] |
CYP3A4 | Progesterone | Increase in expression and activity and no change in expression/activity | [147,149] |
CYP3A4 | Estradiol | Increase in expression and activity and no change in expression/activity | [147,149] |
CYP3A4 | Cortisol | Increased expression and activity | [149,151] |
UGT1A1 | Progesterone | Increased expression | [152] |
UGT1A1 | Estradiol | Increased expression | [153] |
UGT1A1 | Cortisol | No change in expression | [153] |
UGT1A4 | Estradiol | Increased expression | [153] |
UGT1A9 | Estradiol | Increased expression | [154] |
UGT2B7 | Estradiol, estriol, estetrol, progesterone, and cortisol | No change in expression | [152,153] |
CYP: cytochrome P450; UGT: uridine 5’-diphospho-glucuronosyltransferases; GR: glucocorticoid receptor.